Want to see DE:ACT0 full AI Analyst Report?
AlzChem Group AG (ACT0) Ratios
56 Followers
AlzChem Group AG Ratios
DE:ACT0's free cash flow for Q2 2026 was €13.04M. For the 2026 fiscal year, DE:ACT0's free cash flow was increased by €0.00 and operating cash flow was €13.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.49 | 2.48 | 2.62 | 1.62 | 2.00 |
| Quick Ratio | 1.52 | 1.52 | 1.32 | 0.70 | 0.88 |
| Cash Ratio | 0.60 | 0.58 | 0.14 | 0.07 | 0.11 |
| Solvency Ratio | 0.25 | 0.29 | 0.23 | 0.20 | 0.18 |
| Operating Cash Flow Ratio | 1.15 | 1.00 | 0.88 | -0.03 | 0.57 |
| Short-Term Operating Cash Flow Coverage | 21.52 | 13.86 | 8.23 | -0.06 | 4.10 |
| Net Current Asset Value | € -62.79M | € -14.56M | € -44.54M | € -62.28M | € -135.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.11 | 0.15 | 0.24 | 0.15 |
| Debt-to-Equity Ratio | 0.17 | 0.26 | 0.39 | 0.70 | 0.63 |
| Debt-to-Capital Ratio | 0.15 | 0.20 | 0.28 | 0.41 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.12 | 0.17 | 0.23 | 0.16 | 0.30 |
| Financial Leverage Ratio | 2.41 | 2.35 | 2.63 | 2.94 | 4.31 |
| Debt Service Coverage Ratio | 10.51 | 8.38 | 5.97 | 0.82 | 4.36 |
| Interest Coverage Ratio | 47.72 | 31.49 | 19.99 | 12.89 | 22.44 |
| Debt to Market Cap | 0.03 | 0.08 | 0.22 | 0.55 | 0.20 |
| Interest Debt Per Share | 4.55 | 5.42 | 6.40 | 10.15 | 5.64 |
| Net Debt to EBITDA | -0.25 | -0.08 | 0.62 | 1.34 | 0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.59% | 29.43% | 56.24% | 52.14% | 63.54% |
| EBIT Margin | 14.73% | 14.01% | 9.40% | 8.17% | 9.05% |
| EBITDA Margin | 19.47% | 18.76% | 15.12% | 12.55% | 14.66% |
| Operating Profit Margin | 14.73% | 13.05% | 9.66% | 7.21% | 9.05% |
| Pretax Profit Margin | 15.64% | 13.59% | 8.91% | 7.61% | 8.65% |
| Net Profit Margin | 11.29% | 9.76% | 6.40% | 5.54% | 6.53% |
| Continuous Operations Profit Margin | 11.32% | 9.79% | 6.44% | 5.57% | 6.57% |
| Net Income Per EBT | 72.16% | 71.77% | 71.84% | 72.80% | 75.57% |
| EBT Per EBIT | 106.22% | 104.16% | 92.24% | 105.62% | 95.54% |
| Return on Assets (ROA) | 10.27% | 11.18% | 8.15% | 7.11% | 7.31% |
| Return on Equity (ROE) | 24.76% | 26.31% | 21.42% | 20.87% | 31.49% |
| Return on Capital Employed (ROCE) | 16.60% | 19.11% | 15.27% | 13.44% | 12.67% |
| Return on Invested Capital (ROIC) | 11.81% | 13.43% | 10.70% | 7.97% | 9.26% |
| Return on Tangible Assets | 10.33% | 11.26% | 8.22% | 7.16% | 7.35% |
| Earnings Yield | 4.05% | 9.32% | 12.99% | 17.47% | 11.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.94 | 6.54 | 6.59 | 8.77 | 9.14 |
| Payables Turnover | 7.43 | 10.45 | 7.10 | 6.94 | 4.70 |
| Inventory Turnover | 3.31 | 3.87 | 2.08 | 2.12 | 1.79 |
| Fixed Asset Turnover | 2.01 | 2.81 | 2.97 | 2.89 | 2.26 |
| Asset Turnover | 0.91 | 1.15 | 1.27 | 1.28 | 1.12 |
| Working Capital Turnover Ratio | 3.36 | 3.82 | 4.99 | 6.82 | 5.67 |
| Cash Conversion Cycle | 122.47 | 115.27 | 179.06 | 161.09 | 165.67 |
| Days of Sales Outstanding | 61.45 | 55.79 | 55.39 | 41.63 | 39.95 |
| Days of Inventory Outstanding | 110.11 | 94.40 | 175.07 | 172.05 | 203.44 |
| Days of Payables Outstanding | 49.10 | 34.92 | 51.40 | 52.59 | 77.72 |
| Operating Cycle | 171.56 | 150.20 | 230.46 | 213.68 | 243.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.56 | 10.33 | 7.14 | -0.42 | 4.23 |
| Free Cash Flow Per Share | 3.88 | 6.10 | 5.12 | -3.27 | 1.42 |
| Dividend Paid and CapEx Coverage Ratio | 1.18 | 1.90 | 2.33 | -0.11 | 1.18 |
| Capital Expenditure Coverage Ratio | 1.40 | 2.44 | 3.54 | -0.15 | 1.51 |
| Operating Cash Flow Coverage Ratio | 3.10 | 1.99 | 1.16 | -0.04 | 0.77 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.19 | 0.13 | -0.01 | 0.10 |
| Free Cash Flow Yield | 2.50% | 10.70% | 19.55% | -19.37% | 6.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.68 | 10.73 | 7.70 | 5.72 | 8.63 |
| Price-to-Sales (P/S) Ratio | 2.79 | 1.05 | 0.49 | 0.32 | 0.56 |
| Price-to-Book (P/B) Ratio | 6.11 | 2.82 | 1.65 | 1.19 | 2.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 39.94 | 9.35 | 5.12 | -5.16 | 16.44 |
| Price-to-Operating Cash Flow Ratio | 11.43 | 5.52 | 3.67 | -40.56 | 5.54 |
| Price-to-Earnings Growth (PEG) Ratio | 1.35 | 0.19 | 0.53 | 0.62 | 0.21 |
| Enterprise Value Multiple | 14.06 | 5.49 | 3.88 | 3.86 | 4.61 |
| Enterprise Value | 1.54B | 571.21M | 317.23M | 262.97M | 285.48M |
| EV to EBITDA | 14.06 | 5.49 | 3.88 | 3.86 | 4.61 |
| EV to Sales | 2.74 | 1.03 | 0.59 | 0.48 | 0.68 |
| EV to Free Cash Flow | 39.24 | 9.21 | 6.09 | -7.90 | 19.71 |
| EV to Operating Cash Flow | 11.23 | 5.43 | 4.37 | -62.02 | 6.64 |
| Tangible Book Value Per Share | 25.20 | 20.03 | 15.71 | 14.05 | 8.57 |
| Shareholders’ Equity Per Share | 25.36 | 20.20 | 15.88 | 14.15 | 8.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.28 | 0.28 | 0.27 | 0.24 |
| Revenue Per Share | 55.62 | 54.47 | 53.13 | 53.28 | 41.50 |
| Net Income Per Share | 6.28 | 5.31 | 3.40 | 2.95 | 2.71 |
| Tax Burden | 0.72 | 0.72 | 0.72 | 0.73 | 0.76 |
| Interest Burden | 1.06 | 0.97 | 0.95 | 0.93 | 0.96 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.12 | 0.06 | 0.02 | 0.02 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.16 | 1.94 | 2.10 | -0.10 | 1.18 |
Currency in EUR
